Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken. Watch this short video to learn why!

Class II Classification of Devices Detecting Bacterial Protease in Wound Fluid

$9.99

Discover how the FDA’s final rule on classifying the device to detect bacterial protease activity in chronic wound fluid impacts regulatory compliance and innovation. This course covers the significance of the class II designation with special controls and the benefits of the De Novo process in reducing regulatory burdens, ensuring patient safety, and enhancing access to innovative medical solutions.

In this course you will learn the following:
* Understand the classification process and criteria for the device.
* Identify the special controls required for compliance.
* Recognize the benefits of the De Novo classification process in reducing regulatory burdens.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year.  At the end of the one year term, the course will be set to “inactive”. 

Why This Course is Important
Without this course, learners might miss crucial insights into the regulatory processes and compliance requirements that facilitate the safe and effective use of innovative medical devices in chronic wound management.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect Bacterial Protease Activity in Chronic Wound Fluid.

Key regulatory references include:

Course SKU
FR-25-1369-1